Efficacy of treatments for VIPoma: A GTE multicentric series.

Fiche publication


Date publication

août 2021

Journal

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CADIOT Guillaume, Pr LEPAGE Côme


Tous les auteurs :
Brugel M, Walter T, Goichot B, Smith D, Lepage C, Cao CD, Hautefeuille V, Rebours V, Cadiot G, de Mestier L,

Résumé

Vasoactive intestinal peptide-secreting tumor (VIPoma) is a very rare, life-threatening, functioning pancreatic neuroendocrine tumor (pNET). The efficacy of antitumor therapies against functioning symptoms and tumor burden have been poorly described in VIPoma.

Mots clés

Diarrhea, Neuroendocrine tumor, Survival, Treatment, Vipoma

Référence

Pancreatology. 2021 Aug 5;: